Zeria Pharmaceutical Co Ltd banner

Zeria Pharmaceutical Co Ltd
TSE:4559

Watchlist Manager
Zeria Pharmaceutical Co Ltd Logo
Zeria Pharmaceutical Co Ltd
TSE:4559
Watchlist
Price: 2 187 JPY 0.28% Market Closed
Market Cap: ¥96.4B

Zeria Pharmaceutical Co Ltd's latest stock split occurred on Sep 26, 2013

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, Zeria Pharmaceutical Co Ltd traded at 2109.0888 per share. Afterward, the share price was about 1835.11.

The adjusted shares began trading on Sep 26, 2013. This was the only stock split in Zeria Pharmaceutical Co Ltd's history.

Last Splits:
Sep 26, 2013
1-for-1
Pre-Split Price
1 788.4955 2 109.0888
Post-Split Price
1 835.11
Before
After
Last Splits:
Sep 26, 2013
1-for-1

Zeria Pharmaceutical Co Ltd
Stock Splits History

Zeria Pharmaceutical Co Ltd Stock Splits Timeline
Sep 26, 2013
Sep 26, 2013
Split 1-for-1
/1
Pre-Split Price
1 788.4955 2 109.0888
Post-Split Price
1 835.11
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 24, 2026
Cue Biopharma Inc
NASDAQ:CUE
1-for-30
/30
0.5542 16.626 USD 17.695 17.695 USD
Apr 24, 2026
Medical Data Vision Co Ltd
TSE:3902
2-for-7253607
/3626803.5
1684 1684 JPY N/A
Apr 24, 2026
T
Trillion Energy International Inc
CNSX:TCF
1-for-5
/5
0.2 0.2 CAD 0.18 0.18 CAD
Apr 24, 2026
E
ESGL Holdings Ltd
NASDAQ:ESGL
1-for-3
/3
2.35 7.05 USD 2.93 2.93 USD
Apr 24, 2026
Metro Mining Ltd
ASX:MMI
1-for-20
/20
0.067 1.34 AUD 1.3 1.3 AUD
Load More

Zeria Pharmaceutical Co Ltd
Glance View

Market Cap
96.4B JPY
Industry
Pharmaceuticals

Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,690 full-time employees. The firm operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Intrinsic Value
3 809.44 JPY
Undervaluation 43%
Intrinsic Value
Price ¥2 187
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett